Increased cerebrovascular sensitivity to endothelin-1 in a rat model of obstructive sleep apnea: A role for endothelin receptor B

Journal of Perinatology

Volumn 35, Issue 3, 2015, Pages 402-411

  Durgan, David J ^a   Crossland, Randy F ^a   Lloyd, Eric E ^a   Phillips, Sharon C ^a   Bryan, Robert M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cerebrovascular circulation; endothelin receptor A; endothelin receptor B; endothelin 1; obstructive sleep apnea

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR B; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BALLOON; BLOOD PRESSURE; BRAIN ARTERY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; HEART RATE; IMPLANTATION; NONHUMAN; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SHAM PROCEDURE; SLEEP DISORDERED BREATHING; SLEEP PATTERN; TRACHEA; ANIMAL; BRAIN CIRCULATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION; SLEEP APNEA, OBSTRUCTIVE; VASOCONSTRICTION;

EID: 84938514507     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.214     Document Type: Article

References (38)

1. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al. American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118: 1080-1111.
2. Durgan DJ, Bryan RM, Jr. Cerebrovascular consequences of obstructive sleep apnea. J Am Heart Assoc 2012; 1: e000091.
3. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90: 47-112.
4. Capone C, Faraco G, Coleman C, Young CN, Pickel VM, Anrather J et al. Endothelin 1-Dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension 2012; 60: 106-113.
5. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-Dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2004; 286: H388-H393.
6. Crossland RF, Durgan DJ, Lloyd EE, Phillips SC, Reddy AK, Marrelli SP et al. A new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteries. Am J Physiol Regul Integr Comp Physiol 2013; 305: R334-R342.
7. Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol 2012; 84: 147-162.
8. Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K et al. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun 1992; 184: 953-959.
9. Ozaki S, Ohwaki K, Ihara M, Ishikawa K, Yano M. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors. J Biochem 1997; 121: 440-447.
10. Adebiyi A, Thomas-Gatewood CM, Leo MD, Kidd MW, Neeb ZP, Jaggar JH et al. An elevation in physical coupling of type 1 inositol 1,4,5-trisphosphate (IP3) receptors to transient receptor potential 3 (TRPC3) channels constricts mesenteric arteries in genetic hypertension. Hypertension 2012; 60: 1213-1219.
11. Xi Q, Adebiyi A, Zhao G, Chapman KE, Waters CM, Hassid A et al. IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release. Circ Res 2008; 102: 1118-1126.
12. Adebiyi A, Zhao G, Narayanan D, Thomas-Gatewood CM, Bannister JP, Jaggar JH et al.. Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility. Circ Res 2010; 106: 1603-1612.
13. Friedman JK, Nitta CH, Henderson KM, Codianni SJ, Sanchez L, Ramiro-Diaz JM et al. Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity. Vascul Pharmacol 2014; 60: 17-24.
14. Kochukov MY, Balasubramanian A, Noel RC, Marrelli SP. Role of TRPC1 and TRPC3 channels in contraction and relaxation of mouse thoracic aorta. J Vasc Res 2013; 50: 11-20.
15. Noorani MM, Noel RC, Marrelli SP. Upregulated TRPC3 and downregulated TRPC1 channel expression during hypertension is associated with increased vascular contractility in rat. Front Physiol 2011; 2: 42.
16. Nunes KP, Rigsby CS, Webb RC. RhoA/Rho-kinase and vascular diseases: what is the link? Cell Mol Life Sci 2010; 67: 3823-3836.
17. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. Calcium sensitization of smooth muscle mediated by a Rho-Associated protein kinase in hypertension. Nature 1997; 389: 990-994.
18. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-Associated kinases. Mol Pharmacol 2000; 57: 976-983.
19. Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009; 53: 1309-1317.
20. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW et al. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 2005; 54: 2638-2644.
21. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 2011; 91: 1-77.
22. Xu CB, Sun Y, Edvinsson L. Cardiovascular risk factors regulate the expression of vascular endothelin receptors. Pharmacol Ther 2010; 127: 148-155.
23. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L et al. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003; 52: 1188-1194, 1194-5.
24. Johansson S, Povlsen GK, Edvinsson L. Expressional changes in cerebrovascular receptors after experimental transient forebrain ischemia. PLoS ONE 2012; 7: e41852.
25. Johansson SE, Larsen SS, Povlsen GK, Edvinsson L. Early MEK1/2 inhibition after global cerebral ischemia in rats reduces brain damage and improves outcome by preventing delayed vasoconstrictor receptor upregulation. PLoS ONE 2014; 9: e92417.
26. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab 2006; 26: 846-856.
27. Cipolla MJ, Sweet JG, Gokina NI, White SL, Nelson MT. Mechanisms of enhanced basal tone of brain parenchymal arterioles during early postischemic reperfusion: role of ET-1-induced peroxynitrite generation. J Cereb Blood Flow Metab 2013; 33: 1486-1492.
28. Stenman E, Malmsjo M, Uddman E, Gido G, Wieloch T, Edvinsson L et al. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 2002; 33: 2311-2316.
29. Skovsted GF, Kruse LS, Larsen R, Pedersen AF, Trautner S, Sheykhzade M et al. Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion. Br J Pharmacol 2014; 171: 2726-2738.
30. Xu CB, Zheng JP, Zhang W, Liu E, Edvinsson L, Zhang Y et al. Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression. Vascul Pharmacol 2014; 60: 42-48.
31. Cao L, Cao YX, Xu CB, Edvinsson L. Altered endothelin receptor expression and affinity in spontaneously hypertensive rat cerebral and coronary arteries. PLoS ONE 2013; 8: e73761.
32. Cao L, Zhang Y, Cao YX, Edvinsson L, Xu CB. Secondhand smoke exposure causes bronchial hyperreactivity via transcriptionally upregulated endothelin and 5-hydroxytryptamine 2A receptors. PLoS ONE 2012; 7: e44170.
33. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45: 705-709.
34. Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J 1995; 9: 1196-1204.
35. Horinouchi T, Terada K, Higashi T, Miwa S. Endothelin receptor signaling: new insight into its regulatory mechanisms. J Pharmacol Sci 2013; 123: 85-101.
36. Zhu L, Qi XY, Aoudjit L, Mouawad F, Baldwin C, Nattel S et al. Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes. Am J Physiol Renal Physiol 2013; 304: F849-F862.
37. Mehta D, Ahmmed GU, Paria BC, Holinstat M, Voyno-Yasenetskaya T, Tiruppathi C et al. RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem 2003; 278: 33492-33500.
38. Earley S. Endothelium-Dependent cerebral artery dilation mediated by transient receptor potential and Ca2+-Activated K+ channels. J Cardiovasc Pharmacol 2011; 57: 148-153.